providing 20.7% mean weight loss

Novo Nordisk A/S: Wegovy HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss

Wegovy HD demonstrated a mean weight loss of 20.7%1, and around one-third of patients achieved 25% or greater weight loss…